The [TargaCell] non-invasive delivery procedure would make it much easier to enroll patients {in clinical trials}. On current methods, “… where [do] these cells go once they are injected into the wall because clearly most of them don’t remain there for very long.
Gary Schaer, MD
Professor Cardiology & Director of Translational Medicine Research, Rush University, Chicago, IL
Catheter delivery will not be the future of stem cell delivery for heart regeneration…too few cells can be delivered and retained to have this theraphy reach its potential.
…your [Targa Cell’s]technology has the potential to do this…
Douglas Losordo, MD
Executive Vice-President for Global Research & Development & Chief Medical Officer, Caladrius; (while Prof. Cardiology Northwestern University Feinberg School of Medicine)
